DAC: Wellcome Trust Case Control Consortium Data Access Committee

DAC Accession Contact Person Email Access Information
EGAC00000000001 Giselle Kerry datasharing@sanger.ac.uk https://www.wtccc.org.uk/info/access_to_data_samples.shtml

This DAC controls 57 datasets:

Dataset Accession Technology Samplessort descending Description
EGAD00000000017 0 Cord blood control samples from Gambia
EGAD00000000018 0 Severe malaria cases from Gambia
EGAD00010000730 1 WTCCC2 Psychosis Endophenotype samples from UK, Germany, Holland, Spain and Australia using the Affymetrix 6.0 array
EGAD00010000640 21 WTCCC2 Visceral Leishmaniasis samples from Sudanl using Illumina 670k
EGAD00010000638 97 WTCCC2 Visceral Leishmaniasis samples from Indial using Illumina 670k
EGAD00010000636 119 WTCCC2 Visceral Leishmaniasis samples from Brazil using Illumina 670k
EGAD00000000011 Illumina 15K 900 WTCCC1 project Autoimmune Thyroid Disease (ATD) samples
EGAD00000000010 Illumina 15K 957 WTCCC1 project Ankylosing Spondylitis (AS) samples
EGAD00000000012 Illumina 15K 975 WTCCC1 project Multiple Sclerosis (MS) samples
EGAD00000000013 Illumina 15K 1004 WTCCC1 project Breast cancer (BC) samples
EGAD00000000015 Affymetrix 500K 1496 WTCCC project African control samples
EGAD00000000016 Affymetrix 500K 1498 WTCCC project Tuberculosis (TB) samples
EGAD00000000002 Affymetrix 500K 1500 WTCCC1 project samples from UK National Blood Service
EGAD00000000001 Affymetrix 500K 1504 WTCCC1 project samples from 1958 British Birth Cohort
EGAD00000000014 Illumina 15K 1504 WTCCC1 project samples from 1958 British Birth Cohort

Pages

DAC description

Access to summary data and individual-level genotype data is available by application to the Wellcome Trust Case Control Consortium Data Access Committee (CDAC). Access to data will be granted to qualified investigators for appropriate use. The CDAC also controls the individual level genotype data for the 1958 British Birth Cohort samples. For further guidelines, application form and data access agreement, please follow the link below.